Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE
28 Apr 2020 - Angle works with skeleton R&D crew during lockdown
28 Apr 2020 - UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial
31 Mar 2020 - Angle UK, US, Canada operations 'severely disrupted' by Covid-19
31 Mar 2020 - Angle Parsortix Test Used To Help Discover Brain Metastasis
3 Mar 2020 - Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients
27 Feb 2020 - Angle upbeat on recent Parsortix research out of Italy
27 Feb 2020 - Angle upbeat on German research into 'Parsortix'
17 Feb 2020
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE
UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE
Angle works with skeleton R&D crew during lockdown
(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a re...
UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial
UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial
Angle UK, US, Canada operations 'severely disrupted' by Covid-19
(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid...
Angle Parsortix Test Used To Help Discover Brain Metastasis
Angle Parsortix Test Used To Help Discover Brain Metastasis
Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients
Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients
Angle upbeat on recent Parsortix research out of Italy
(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results o...
Angle upbeat on German research into 'Parsortix'
(Sharecast News) - Liquid biopsy company Angle announced on Monday that University Medical Centre Hamburg-Eppendorf has published results of work unde...
Follow the stocks
